Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Blood Specimen Collection × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Thrombosis 2 Skin Neoplasms 2 Myelodysplastic Syndromes 2 Hodgkin Disease 2 Desmoid Tumors 2 COVID-19 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Sezary Syndrome 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Mesothelioma 1 Meningeal Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1

Interventions

pembrolizumab 2 fludarabine 2 blinatumomab 2 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 relugolix 1 nilotinib 1 isatuximab 1 inavolisib 1 giredestrant 1 fludarabine phosphate 1 enzalutamide 1 abemaciclib 1 Transplantation 1 Monatide (IMS 3015) 1 Melphalan 1 Lenalidomide 1 Immunotherapy 1 Imatinib Mesylate 1 HMPL-013 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Biological Assay 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡